Xerient Pharma - Crunchbase Company Profile & Funding

Q: Where is Xerient Pharma's headquarters?

Xerient Pharma is located in Petah Tiqva, HaMerkaz, Israel.

Q: Who invested in Xerient Pharma?

Xerient Pharma is funded by Peregrine Ventures.

Q: When was the last funding round for Xerient Pharma?

Xerient Pharma closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Xerient Pharma raised to date?

Xerient Pharma has raised obfuscated.

Overview

Xerient Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Xerient Pharma

CB Rank

161938

Xerient Pharma is a developer of treatments and diagnostic technologies intended for the treatment of cancer.

Founded

obfuscation

Private

Venture - Series Unknown

Petah Tiqva, HaMerkaz, Israel

xerient.net/

Biopharma

Biotechnology

Health Care

Health Diagnostics

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Details

Legal Name

Xerient Pharma Ltd.

Operating Status

Active

Company Type

For Profit

About the Company

Xerient Pharma is a developer of treatments and diagnostic technologies intended for the treatment of cancer. The company focuses on unmet needs in cancer treatment, particularly in abdominal and gastrointestinal cancers, and pursues the development of novel therapeutic technology that can dramatically improve the survival of these patients.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Radioprotective Therapeutic

A therapeutic solution that enables the localized treatment of pancreatic cancer by protecting nearby sensitive organs, such as the duodenum, from the harmful effects of radiotherapy.

Repurposed FDA-Approved Drug

An FDA-approved drug repurposed for oral administration to protect the gastrointestinal tract from radiation injury during cancer treatment.

Research & Development

Xerient Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Xerient Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Peregrine Ventures	—	Venture Round - Xerient Pharma	—
Peregrine Ventures	—	Venture Round - Xerient Pharma	—
Peregrine Ventures	—	Venture Round - Xerient Pharma	—
Peregrine Ventures	—	Venture Round - Xerient Pharma	—
Peregrine Ventures	—	Venture Round - Xerient Pharma	—